Clinical trial
Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B)
NCT00252239 · University of Virginia, Other · Terminated
Key facts
| NCT number | NCT00252239 |
|---|---|
| Title | Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B) |
| Official title | Phase 2B Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B) |
| Lead sponsor | University of Virginia, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stroke |
| Intervention type | Drug |
| Interventions | tenecteplase, tissue plasminogen activator, tPA |
| Enrollment | 112 |
| Start date | Nov 1, 2005 |
| Primary completion | Mar 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Nov 11, 2005 |
| Last update posted | Mar 17, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: